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Abstract
We recently encountered an unusual case of Composite lymphoma (CL) in the anterior mediastinum arising in a
37-year-old woman who presented initially with continuous pain in the right shoulder and chest. The woman had
been suffered from continuous pain for three months before she went to our department of cardiovascular
surgery. Chest computed tomography scan revealed the oval space-occupying lesion of anterior mediastinum.
Surgery was performed and the disease was diagnosed pathologically as CL which composed of nodular sclerosing
Hodgkin lymphoma and diffuse large B-cell lymphoma, via hematoxylin-eosin (H&E), immunohistochemical staining
and in situ hybridization.
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Background
Composite lymphoma (CL), which is defined as the
coexistence of two morphologically and phenotypically
distinct types of lymphoid neoplasms occurring in a sin-
gle anatomic organ or tissue, is unusual [1,2]. The com-
bination might include Hodgkin lymphoma (HL) with
B-cell or a T-cell non-Hodgkin lymphoma (NHL), B-cell
N H Lw i t hT- c e l lN H L ,o rt w od i s t i n c tB - c e l lo rT - c e l l
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“composite lymphoma” was first put forward by Custer
RP to expatiate the occurrence of more than one histo-
logical type of lymphoma in the same patient [7]. The
incidence of CL is low, varying from 1% to 4.7% [8]. In
our present study, we report a case of composite nodu-
lar sclerosing Hodgkin lymphoma (NSHL) and diffuse
large B-cell lymphoma (DLBCL) in the anterior medias-
tinum. The clinical, histopathologic, immunohistochem-
ical features and the clinical prognosis are discussed.
Case presentation
The 37-year-old woman presented with a three-month
history of continuous pain in the right shoulder and
chest. She was taken to our department of cardiothor-
acic surgery. Physical examination was remarkable for
palpable lymph nodes in the bilateral supraclavicular
fossae. Chest computed tomography (CT) revealed an
oval mass located in the anterior mediastinum. Circu-
mambient lung tissue was involved. Haematological
findings were: WBC 15.40 × 10
9/L, platelets 364 × 10
9/
L, prothrombin time 10.3 sec. Her erythrocyte sedimen-
tation rate (ESR), blood biochemistry, electrolytes, blood
urea nitrogen and serum creatinine, urine analysis and
the endocrine profile were within normal range except
hemoglobin (106 g/L) and tumor specific growth factor
(67 U/ML). The abdominal ultrasonography did not
reveal any other abnormality.
The surgery was performed with the patient under
general anesthesia and left lateral decubitus position.
The procedure revealed an oval tumor, volume of which
was 7 cm × 4.5 cm × 2.5 cm, in the anterior mediasti-
num and circumambient lung tissue was involved.
Pathologic findings during surgery showed that the
tumor was off-white with obscure boundaries and hard
in consistence (Figure 1). The result of pathology hinted
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and circumambient lung tissue which was involved were
excised.
Histology showed the tumor was nodular and different
nodules were separated by collagen fibers (Figure 2A).
There were two morphologically and immunophenotypi-
cally distinct components. The great mass of nodules
showed a pleomorphic cellular infiltrate containing lym-
phocyte, eosinophile granulocyte, neutrophile granulo-
cyte and numerous large Hodgkin/Reed-Sternberg cells.
The Reed-Sternberg cells were positive for CD30, CD15
and MUM1 but negative for CD20, CD79a, CD3, Pax-5,
CD68, bcl-6, CD10, CD45, Ig,I g l and epithelial mem-
brane antigen (Figure 2B, Figure 3A). Other nodules
Figure 1 Gross morphology of the tumor. The cut section of the tumor is off-white with obscure boundaries and hard in consistence. Volume
of the tumor is 7 cm × 4.5 cm × 2.5 cm.
Figure 2 Histological examination. (A)The tumor is nodular and different nodules are separated by collagen fibers. Different nodules show
different histologic features (H&E × 40). (B) Pleomorphic cellular infiltrate containing lymphocytes, eosinophils, neutrophils and large Reed-
Sternberg cells (arrows) (H&E × 400). (C) Other nodules display sheets of relatively uniform large lymphoid cells with typical morphologic features
of large cell lymphoma (H&E × 100).
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cells with typical morphologic features of large cell lym-
phoma which showed uniform expression of CD20,
CD79a, MUM1, CD45, Igl, Pax-5 and absence of CD30,
CD15, CD3, CD10, bcl-6, Ig, CD68 and epithelial
membrane antigen (Figure 2C, Figure 3B). All the pri-
mary antibodies are listed in Table 1. Neither cell popu-
lation showed makers of EBV infection by EBER in situ
hybridization (PanPath Company, Amsterdam, Nether-
lands). On the basis of histomorphology at light micro-
scopy, the presence of immunohistochemical staining
and in situ hybridization, a diagnosis of CL, combination
of NSHL and DLBCL, in the anterior mediastinum was
made. The patient received six courses of CHOP che-
motherapy (a course of treatment every two weeks) and
twenty three times radiotherapy (Gross Tumor Volume,
GTV = 40Gy/20f; Planning Target Volume, PTV = 36
Gy/20f). After treatment, lymph nodes in the bilateral
supraclavicular fossa disappeared. The total follow-up
period was thirty three months after surgery. The
repeated CT scans, abdominal ultrasonography and
tumor specific growth factor every three months
revealed no recurring or residual lesion.
Discussion
Clinically, manifestation of CL is similar with that of
ordinary lymphoma. The true incidence of CL occurring
in the same tissue is difficult to estimate because of the
pathologist and the classification system used. In the
study of more than one thousand of cases for Working
Formulation of NHL, the incidence of CL varied
between 1 and 4.7% [6,9]. The combination of classical
Hodgkin lymphoma and non-Hodgkin lymphoma coex-
isting in the same tissue is rare and much more uncom-
mon than other combinations. To our best knowledge,
Kim et al firstly reported the patient with CL consisting
of an admixture of HL and NHL in the left axillary
node [10]. According to our literature search, only six
cases showing combination of classical Hodgkin lym-
phoma and DLBCL within the same site simultaneously
were described [11-15]. The clinical data of all pre-
viously published cases of classical Hodgkin lymphoma
associated with DLBCL was listed in Table 2.
Lymphoma, generally, is defined as monoclonal prolif-
eration of lymphocyte (T cell, B cell or natural killer
cell) while polyclonal hyperplasia is generally regarded
as reactive lymphoid proliferation. However, the patho-
genesis of CL is not clear. Many studies of CL using
molecular techniques have proved true biclonality as
well as a common origin from the same clonal progeni-
tor cell and suggested different biological mechanisms
in different tumors [4,13,14,16-18]. As far as the
Figure 3 Immunohistochemical features of the tumor. (A)Immunohistochemical study demonstrates that Reed-Sternberg cells are positive for
CD30 (Envision × 100). (B) Immunohistochemical study shows that diffuse large B-cell lymphoma cells is positive for CD20 (Envision × 100).
Table 1 Antibodies employed in the
immunohistochemistry applied
Antibody Clone Source Dilution
Anti CD3 SP7 Lab Vision 1:100
Anti CD20 L26 Lab Vision 1:100
Anti CD79a SP18 Lab Vision 1:100
Anti CD45 PD7/26+2B11 Lab Vision 1:100
Anti CD10 56C6 Lab Vision 1:100
Anti CD15 Carb-3 Lab Vision 1:100
Anti CD30 Ber-H2 Lab Vision 1:100
Anti CD68 KP1 Lab Vision 1:100
Anti MUM1 MUM1p Lab Vision 1:100
Anti Pax-5 SP34 Lab Vision 1:100
Anti Bcl-6 LN22 Dako 1:100
Anti Igk L1C1 Lab Vision 1:100
Anti Igl LAM03+HP6054 Lab Vision 1:100
Yu et al. Diagnostic Pathology 2011, 6:60
http://www.diagnosticpathology.org/content/6/1/60
Page 3 of 7combination of HL and B-cell NHL is concerned, the
most common form is nodular lymphocyte predomi-
nance Hodgkin lymphoma (NLPHL) with large cell lym-
phoma [6]. The both components may occur
synchronously and successively. More and more
researchers swing the pendulum towards that HL and
B-cell NHL coexisting in the same tissue might originate
from a common precursor by molecular techniques
[13,14,19]. Bräuninger et al studied CL from one patient
( c l a s s i cH La n daf o l l i c u l a rl y m p h o m ai nt h es a m e
lymph node). A V gene rearrangement and some
somatic mutations were shared by Reed-Sternberg cells
and follicular lymphoma cells, which provided proof of a
common B-cell precursor [16]. Schmitz et al summar-
ized six cases of such CL in which the HLs were com-
bined in two cases with follicular lymphoma, and in one
case each with B-cell chronic lymphocytic leukemia,
marginal zone lymphoma, mantle cell lymphoma and
DLBCL. The composite lymphomas had been analyzed
by single-cell PCR analysis for rearranged IgV genes and
a clonal relationship was confirmed [16,20,21]. In the
cases of NLPHD with associated LBCL, the presence of
a clonal population in the NLPHD component that was
identical or related to the neoplastic clone of the asso-
ciated LBCL has been found. In addition, in situ hybridi-
zation has shown that both L&H cells and LBCL cells
expressed the same type of the immunoglobulin light
chain messenger RNA. Single L&H cells, the Reed-
Sternberg cells variants in NLPHD, were isolated from
immunostained tissue sections by micromanipulation,
and the IgH complementarity determining region (CDR)
III of the cells was amplified by PCR. The sequences
from the L&H cells also were related to those from the
corresponding LBCL cells. All of these findings strongly
suggested that NLPHD was related to the corresponding
LBCL [19,22].
We have analysed our case of a patient with NSHL,
presenting a distinct focal area of proliferation com-
posed of large monomorphous NHL cells in the anterior
mediastinum. On immunohistochemical analysis, typical
Reed-Sternberg cells expressed CD 30, CD 15 and
MUM1 antigens, but lacked CD20 and Pax-5 immunor-
eactivity. The large monomorphous NHL cells reacted
with the antibodies CD20, CD79a, MUM1 and Pax-5,
showing a B-cell-related phenotype, and no other
expression of the antigens was expressed by Reed-Stern-
berg cells expect MUM1 protein. Unfortunately, we
could not perform further molecular investigations in
order to determine whether a clonal relationship
between the Reed-Sternberg cells and the DLBCL cells
does exist in our patient. Thus, we can only offer specu-
lations on this intriguing issue according to the existing
literatures. Two main possibilities may be considered, as
follows in Table 3.
First, both NSHL and DLBCL originate from a com-
mon precursor B cell, that is, the same abnormal B cell
gives rise to the different neoplastic disorders through
distinct bilogical pathways. Bellan et al reported that
immunoglobulin heavy chain gene (IgH) rearrangement
was found in the VH region in Reed-Sternberg cells and
LBCL cells. A repeated VH4DH3JH4 segment was
observed in Reed-Sternberg cells, while a repeated
VH3DH3JH4 segment was found in LBCL cells. The two
populations showing the same JH and DH segments with
Table 2 Clinical data of previously published cases of classical Hodgkin lymphoma with DLBCL
No./Series Age
(years)
Sex Site of
biopsy
Clinical Presentation Subtype
of cHL
Treatment Follow-
up
Months
Status
1/Paulli et al 1992 37 Male LN in the
right SF
Intermittent fever
and malaise
NS Eight cycles of pro-MACE-CytaBOM 23 ANED
2/Huang et al 2006 56 Male Small
intestine
Bowel perforation NS The lesion was resected 6 days
after
surgey
DOD
3/Bellan et al 2002 29 Female Laterocervical
LN
Left LL extending to
the SF
NS MACOP-B chemotherapy for 8
weeks and transplant of
autologous stem cells
30 ANED
4/Rosenquist et al
2004
74 Female LN in the
right inguinal
Abdominal pain MC Six cycles of CHOP 12 ANED
5/Hell et al
1995
NA NA LN NA NS NA NA NA
6/Hell et al
1995
NA NA LN NA NS NA NA NA
7/Present case 37 Female mediastinum continuous pain in
the right shoulder
and chest
NS six courses of CHOP chemotherapy
and twenty three times
radiotherapy
33 ANED
Abbreviations: cHL, classical Hodgkin Lymphoma; NS, nodular sclerosis; MC, mixed cellularity; LN, lymph node; SF, supraclavicular fossa; LL, laterocervical
lympadenopathy; ANED, alive with no evidence of disease; DOD, died of disease; NA, not available.
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derived from a common B cell origin [14]. In addition,
clonally related Vgene rearrangement was also found in
both Reed-Sternberg cells and DLBCL cells which
revealed a common lymphoma precursor [15]. During
t h ec o u r s eo fn e o p l a s t i cp r o g r e s s i o n ,b o t hN S H La n d
DLBCL were assumed to share one or more transform-
ing events, which might play an important role in the
up-regulation or down-regulation of tumor associated
antigens. For example, Pax-5 is an important B-cell
transcription factor and expressed regularly in the Reed-
Sternberg cells of HL. But this antigen could be lost in
the Reed-Sternberg cells, which was caused by some
transforming event in the tumorigeness of CL [13].
Epstein-Barr virus (EBV) was identified in a subset of
cases of HL and in some NHL, particularly those asso-
ciated with immunodeficiency [23]. However, EBV infec-
tion did not seem to be the primary event in this
tumorigeness by assessing the data of table 3. Second,
Paulli et al suggested the NSHL and DLBCL compo-
nents were totally unrelated and their occurrence
together within the same lymph node simply repre-
sented a coincidental occurrence [12]. However, this
result might be inconclusive which was supported by
immunohistochemical research and lacked the molecu-
lar studies.
Primary mediastinal large B-cell lymphoma (PMBCL)
is the most critical disease in distinguishing with
DLBCL of CL. PMBCL is currently classified as a sub-
type of diffuse large B-cell lymphoma, which has distinct
clinical and molecular features, many of which are simi-
lar with that of NSHL [24]. PMBCL shows the clinical
presentation of a large anterior mediastinal mass in a
young female, but it does not express immunoglobulin
[24-26]. In our present study, large B-cell lymphoma
cells expressed Igl which could help us differ it from
PMBCL. In addition, there is a lack or defective expres-
sion of HLA class I or II molecules and an over-expres-
sion of MAL or interleukin-4 inducible gene FIG1 is
always found in PMBCL [27]. Secondly, mediastinal gray
zone lymphoma (MGZL), which represents two kinds of
manifestation, should also be considered in differential
diagnosis. In some cases, the histologic appearance is
more suggestive of MLBCL, but the immunohistochem-
ical features are characteristic of classical HL with
expression of CD15 and CD30, and weak or absent
CD20 positivity. In other cases, the histology is more
reminiscent of classical HL, but the immunophenotype
is more suggestive of a DLBCL. In our case, morpholo-
gic and immunohistochemical features have shown two
different neoplasms. The Reed-Sternberg cells were
positive for CD30, CD15 but negative for CD20,
CD79a, CD45, while large B-cell lymphoid cells
showed expression of CD20, CD79a, CD45 and
absence of CD30, CD15. Other histological differential
diagnoses, including leukocythemia, carcinoma metas-
taticum, sarcoma, reactive lymphoid proliferation and
collision tumor [28] should be cautiously considered.
Careful observation under the microscope and properly
performed immunohistochemistry could be helpful for
a correct diagnosis [2].
There is no evidence that the clinical course of CL dif-
fers significantly from that of discordant lyomphoma or
lymphoma in general when the component with the
poorest prognosis is taken into consideration. Although
the case is rare and the number of reported cases is
small, most scholars suggest that the prognosis is
depended by the unfavorable component of CL.
Table 3 Clinical features of previously published cases of classical Hodgkin lymphoma with DLBCL
NO. Clonal identity Component CD3 CD20 CD15 CD30 Immunostaining Results ISH Results EBER
Ig Igl Igl
1 NO RS cells - - + + - - NA NA NA
LBCL cells - + - - - - NA NA NA
2 Yes RS cells - - + + NA NA NA NA +
LBCL cells - + - - NA NA NA NA -
3 Yes RS cells - - + + - - NA NA -
LBCL cells - + - + - - NA NA -
4 Yes RS cells - - +/- + NA NA NA NA -
LBCL cells - + - - NA NA NA NA -
5 NI RS cells - + + + + + - - NA
LBCL cells - + - - - - + - NA
6 NI RS cells - - + + + + - - NA
LBCL cells - + - - + + + - NA
7 Yes? RS cells - - + + - - NA NA -
LBCL cells - + - - - + NA NA -
Abbreviations: ISH, in situ hybridization; NA, not available; NI, not indicated
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ingredient [2,29]. The treatment for the patient we pre-
sented was CHOP chemotherapy and adjuvant radiation
therapy after surgery. The necessary follow-up examina-
tion among thirty three months disclosed there was no
palindromic lesion.
Conclusion
We report a rare case of CL, combination of nodular
sclerosing Hodgkin lymphoma and diffuse large B-cell
lymphoma, arising in the anterior mediastinum. By
molecular techniques, many scholars have proved the
two different ingredients tend to origin from the same
clonal progenitor cell. EBV infection is not essential
transforming event during the course of tumorigenesis.
The contribution of immunohistochemstry plays an
important role in differential diagnoses. Therapeutic
decision of CL should be based on the component of
which malignant degree is higher.
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